文献速递糖尿病肥胖与代谢综合征

外周胰岛素抵抗而非β细胞功能障碍解释了撒哈拉以南非洲个体空腹血糖受损的地理差异:RODAM研究结果

Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study.
PubMed 文献 · Diabetologia · 2017-01-31

基于RODAM横断面多中心研究,纳入无糖尿病的加纳裔成人(阿姆斯特丹1337人、柏林502人、伦敦961人、加纳城市1309人、加纳农村970人)。与加纳农村参照人群相比,加纳城市、阿姆斯特丹和伦敦的空腹血糖受损(IFBG)风险更高,柏林相似;HOMA-IR每增加1个标准差对IFBG的归因风险为69.3%,而逆HOMA-B为11.1%。调整HOMA-IR后,加纳城市和伦敦的IFBG风险不再显著,阿姆斯特丹风险降低但仍有统计学意义;调整逆HOMA-B影响很小。结论提示胰岛素抵抗而非β细胞功能障碍在解释IFBG地理差异中更重要。

要点

  • 与加纳农村相比,加纳城市、阿姆斯特丹和伦敦的IFBG风险更高,柏林无显著差异。
  • HOMA-IR每增加1个标准差对IFBG的归因风险为69.3%,逆HOMA-B为11.1%。
  • BMI和腰围与HOMA-IR升高关联最强,年龄和过量饮酒与逆HOMA-B关联最强。

核心结论

  • 研究提示胰岛素抵抗而非β细胞功能障碍在解释撒哈拉以南非洲个体IFBG的地理差异中更重要,BMI和腰围是该人群胰岛素抵抗的重要因素。

研究设计与样本

  • 横断面多中心研究(RODAM研究),纳入无糖尿病的加纳裔18-96岁成人,居住于阿姆斯特丹(n=1337)、柏林(n=502)、伦敦(n=961)、加纳城市(n=1309)和加纳农村(n=970)。

主要发现

  • 与加纳农村参照人群相比,IFBG的OR为:加纳城市1.41(95%CI 1.08, 1.84)、阿姆斯特丹3.44(95%CI 2.69, 4.39)、伦敦1.58(95%CI 1.20, 2.08),柏林1.00(95%CI 0.70, 1.45)。
  • HOMA-IR每增加1个标准差对IFBG的归因风险为69.3%,逆HOMA-B每增加1个标准差为11.1%。
  • 调整HOMA-IR后,与加纳农村相比,IFBG的OR变为:加纳城市0.96(95%CI 0.72, 1.27)、阿姆斯特丹2.52(95%CI 1.94, 3.26)、伦敦1.02(95%CI 0.78, 1.38);调整逆HOMA-B对ORs影响很小。
  • 多变量分析中,BMI(β=0.17 [95%CI 0.11, 0.24])和腰围(β=0.29 [95%CI 0.22, 0.36])与较高HOMA-IR关联最强;年龄(β=0.20 [95%CI 0.16, 0.23])和过量饮酒(β=0.25 [95%CI 0.07, 0.43])与逆HOMA-B关联最强。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to assess the extent to which insulin resistance and beta cell dysfunction account for differences in impaired fasting blood glucose (IFBG) levels in sub-Saharan African individuals living in different locations in Europe and Africa. We also aimed to identify determinants associated with insulin resistance and beta cell dysfunction among this population. METHODS: Data from the cross-sectional multicentre Research on Obesity and Diabetes among African Migrants (RODAM) study were analysed. Participants included Ghanaian individuals without diabetes, aged 18-96 years old, who were residing in Amsterdam (n = 1337), Berlin (n = 502), London (n = 961), urban Ghana (n = 1309) and rural Ghana (n = 970). Glucose and insulin were measured in fasting venous blood samples. Anthropometrics were assessed during a physical examination. Questionnaires were used to assess demographics, physical activity, smoking status, alcohol consumption and energy intake. Insulin resistance and beta cell function were determined using homeostatic modelling (HOMA-IR and HOMA-B, respectively). Logistic regression analysis was used to study the contribution of HOMA-IR and inverse HOMA-B (beta cell dysfunction) to geographical differences in IFBG (fasting glucose 5.6-6.9 mmol/l). Multivariate linear regression analysis was used to identify determinants associated with HOMA-IR and inverse HOMA-B. RESULTS: IFBG was more common in individuals residing in urban Ghana (OR 1.41 [95% CI 1.08, 1.84]), Amsterdam (OR 3.44 [95% CI 2.69, 4.39]) and London (OR 1.58 [95% CI 1.20 2.08), but similar in individuals living in Berlin (OR 1.00 [95% CI 0.70, 1.45]), compared with those in rural Ghana (reference population). The attributable risk of IFBG per 1 SD increase in HOMA-IR was 69.3% and in inverse HOMA-B was 11.1%. After adjustment for HOMA-IR, the odds for IFBG reduced to 0.96 (95% CI 0.72, 1.27), 2.52 (95%CI 1.94, 3.26) and 1.02 (95% CI 0.78, 1.38) for individuals in Urban Ghana, Amsterdam and London compared with rural Ghana, respectively. In contrast, adjustment for inverse HOMA-B had very minor impact on the ORs of IFBG. In multivariate analyses, BMI (β = 0.17 [95% CI 0.11, 0.24]) and waist circumference (β = 0.29 [95%CI 0.22, 0.36]) were most strongly associated with higher HOMA-IR, whereas inverse HOMA-B was most strongly associated with age (β = 0.20 [95% CI 0.16, 0.23]) and excess alcohol consumption (β = 0.25 [95% CI 0.07, 0.43]). CONCLUSIONS/INTERPRETATION: Our findings suggest that insulin resistance, rather than beta cell dysfunction, is more important in accounting for the geographical differences in IFBG among sub-Saharan African individuals. We also show that BMI and waist circumference are important factors in insulin resistance in this population.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Meeks KAC, Stronks K, Adeyemo A, et al. Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study. Diabetologia. 2017. PMID: 28144712. doi:10.1007/s00125-017-4216-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。